1st known U.S. case of Brazil COVID-19 variant found in Minnesota

The Minnesota Department of Health announced on Monday it has recorded the first known case in the U.S. of the highly transmissible COVID-19 variant that has been spreading through Brazil.
Known as the P.1 variant, it was detected amid a surge of cases in Manaus, Brazil. Minnesota health officials said the patient is a resident of the Twin Cities area who recently traveled to Brazil, and the strain was found via genomic sequencing of random blood samples. The person was tested on Jan. 9, and is now in isolation. Ruth Lynfield, Minnesota's state epidemiologist, said this is a reminder why "it is so important to limit travel during a pandemic as much as possible."
Scientists are closely studying three COVID-19 variants: P. 1, as well as B.1.1.7, first detected in the United Kingdom, and B1.351, first identified in South Africa. Virologists said the variants are independent of one another but there is some overlap in the mutations. The U.K. variant is spreading now in the U.S., but the South Africa variant has not yet been detected. Virologists are especially concerned that the Brazil and South Africa variants contain mutations that may evade the protections of some antibodies.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
William Hanage, an epidemiologist at the Harvard T. H. Chan School of Public Health, told The Washington Post on Monday the Brazil variant is "probably the one causing the most concern among people watching this. It is fair to say that P.1 is the object of very, very serious attention and concern among epidemiologists. We don't know why it has been so successful in Manaus."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Quiz of The Week: 1 - 7 March
Have you been paying attention to The Week's news?
By The Week Staff Published
-
Superboys of Malegaon: 'uplifting' Indian love letter to scrappy filmmaking
The Week Recommends 'Feelgood' comedy about a group of friends who make their own versions of Bollywood hits
By The Week UK Published
-
The week's best photos
In Pictures Rio’s dirtiest party, a pancake-flipping race, and more
By Anahi Valenzuela, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published